- https://www.rki.de/DE/Content/Infekt/Impfen/ImpfungenAZ/COVID-19/Impfempfehlung-Zusfassung.html
- Premature infants receive an additional vaccine dose at the age of 3 months; in total they receive 4 doses
- For more information on specific population groups where measles vaccination is mandatory please refer to https://www.masernschutz.de/themen/rechtliche-aspekte.html
- TIV may also be replaced by QIV (quadrivalent) or aTIV (adjuvanted TIV) vaccine
- For a full description of currently applicable COVID-19 recommendations, please refer to https://www.rki.de/DE/Content/Infekt/Impfen/ImpfungenAZ/COVID-19/Impfempfehlung-Zusfassung.html
- Booster doses every 10 years. catch-up for those unvaccinated
- The next due Td 10-yearly booster dose should be with a Tdacp vaccine. Subsequent booster doses are to be done with Td vaccines.
Vaccination offered to pregnant women at the beginning of 3rd trimester. If there is an increased probability of premature birth, vaccination should be brought forward to the 2nd trimester. More information available at: RKI - Vaccinations A - Z - Scientific justification for recommending pertussis vaccination with a Tdap combination vaccine in pregnancy
- catch-up for those unvaccinated
- see recommendation details for at-risk groups where vaccination is recommended https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/39_23.pdf?__blob=publicationFile
- change of recommendations in Sept 2023 moving away from PPSV23. For individuals previously vaccinated with PPSV23, a dose of PCV20 is recommended in an interval of at least 6 years after PPSV23 dose. for more details refer to https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/39_23.pdf?__blob=publicationFile for more information
- one dose of measles for those aged 18 years and older and born after 1970 with no vaccination or uncertain vaccination history or only one vaccination during childhood
- Annual vaccination
- 2 doses with a minimal and maximum interval of 2 to 6 months respectively between doses.
Vaccination with the inactivated herpes zoster subunit vaccine. see recommendation background paper: https://link.springer.com/article/10.1007/s00103-019-02882-5
More information available at:
https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Impfempfehlungen_node.html
---------------------------------------------------------------------------------------
01 March 2021: new measles mandatory vaccination requirements for specific population groups
https://www.masernschutz.de/themen/rechtliche-aspekte.html
---------------------------------------------------------------------------------------
22 August 2019: Launch of the 2019/2020 vaccination schedule
change include updated recommendation for Herpes-Zoster with an inactivated vaccine. see for more info: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben/50_18.pdf%3F__blob%3DpublicationFile
---------------------------------------------------------------------------------------
31 August 2017: Publication of the 2017/2018 vaccination schedule
Changes include:
- A decision NOT to implement routine ZOSTER vaccination (immunisation is to be decided on a case-by-case basis)
- A revised policy for FLU vaccination of children aged 2-17 years
- For TETANUS post-exposure prophylaxis - ONLY recommended if a last dose was given more than 10 years ago. This applies to limited, clean wounds
- For HepA/HepB vaccination ; revision of the groups where vaccination is recommended
For more information, please refer to https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2017/Ausgaben/35_17.pdf?__blob=publicationFile
---------------------------------------------------------------------------------------
The German immunisation calendars in 16 foreign languages can be found here:
http://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Impfkalender_mehrsprachig_Uebersicht_tab.html?nn=2709264
---------------------------------------------------------------------------------------
Recommendation for children with underlying medical conditions:
Vaccination recommendations for children with underlying medical conditions or specific health risks currently exist for the following diseases: Haemophilus influenzae type b, hepatitis A and B, influenza, meningococcal infections (groups A, C, W135, Y), and pneumococcal diseases. Specifics of those recommendations can be found in English at: www.stiko.de/en
---------------------------------------------------------------------------------------
Sept. 2023:
Pneumococcal vaccination: recommendation change for adults. see for more details: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/39_23.pdf?__blob=publicationFile
---------------------------------------------------------------------------------------
January 2025 Introduction of the MenB vaccine.
----------------------------------------------------------------------------------------
Date of last update: 12 February 2025